Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPP-ACPF vs propolis for dentin hypersensitivity
IRCT20120901010703N4Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of casein phosphopeptide-amorphous calcium phosphate + fluoride and propolis in Dentinal hypersensitivity (DH) (2 arms), sponsored by Isfahan University of Medical Sciences. Started Nov 2020; status: completed.
02
Drugs
casein phosphopeptide-amorphous calcium phosphate + fluoridepropolis
03
Conditions
Dentinal hypersensitivity (DH)
Beyond the preview
Go deeper on IRCT20120901010703N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120901010703N4.